TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs1351383
log Bayes Factor = 79.9659
Chromosome 6   position 32,822,269  (GRCh37) Explore rs1351383 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
1.000 0.000 0.000
E10.9 Without complications
1.000 0.000 0.000
K90.0 Coeliac disease
1.000 0.000 0.000
E05 Thyrotoxicosis [hyperthyroidism]
1.000 0.000 0.000
E10 Insulin-dependent diabetes mellitus
1.000 0.000 0.000
E00-E07 Disorders of thyroid gland
1.000 0.000 0.000
E10.3 With ophthalmic complications
1.000 0.000 0.000
E03 Other hypothyroidism
1.000 0.000 0.000
E05.9 Thyrotoxicosis, unspecified
1.000 0.000 0.000
E10.1 With ketoacidosis
1.000 0.000 0.000
E10-E14 Diabetes mellitus
1.000 0.000 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.999 0.001 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.995 0.005 0.000
E10.4 With neurological complications
0.973 0.027 0.000
E10.8 With unspecified complications
0.972 0.028 0.000
E20-E35 Disorders of other endocrine glands
0.958 0.042 0.000
E10.5 With peripheral circulatory complications
0.938 0.062 0.000
E10.2 With renal complications
0.937 0.063 0.000
E24 Cushing's syndrome
0.926 0.074 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.914 0.086 0.000
E10.0 With coma
0.896 0.103 0.000
E14 Unspecified diabetes mellitus
0.882 0.118 0.000
E23 Hypofunction and other disorders of pituitary gland
0.869 0.131 0.000
E16 Other disorders of pancreatic internal secretion
0.853 0.147 0.000
E24.9 Cushing's syndrome, unspecified
0.839 0.161 0.000
E28 Ovarian dysfunction
0.829 0.171 0.000
E23.2 Diabetes insipidus
0.828 0.172 0.000
E14.3 With ophthalmic complications
0.824 0.176 0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.804 0.196 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.800 0.200 0.000
E24.0 Pituitary-dependent Cushing's disease
0.796 0.204 0.000
E40-E46 Malnutrition
0.788 0.212 0.000
E16.2 Hypoglycaemia, unspecified
0.783 0.217 0.000
E28.3 Primary ovarian failure
0.777 0.223 0.000
E83.1 Disorders of iron metabolism
0.000 0.226 0.774
E03.8 Other specified hypothyroidism
0.773 0.227 0.000
E24.2 Drug-induced Cushing's syndrome
0.764 0.236 0.000
E10.6 With other specified complications
0.761 0.239 0.000
E29 Testicular dysfunction
0.758 0.242 0.000
E10.7 With multiple complications
0.758 0.242 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.757 0.243 0.000
E07 Other disorders of thyroid
0.748 0.252 0.000
E14.8 With unspecified complications
0.744 0.256 0.000
E05.5 Thyroid crisis or storm
0.717 0.283 0.000
E05.4 Thyrotoxicosis factitia
0.717 0.283 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.717 0.283 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.717 0.283 0.000
E00 Congenital iodine-deficiency syndrome
0.717 0.283 0.000
E03.5 Myxoedema coma
0.717 0.283 0.000
E03.4 Atrophy of thyroid (acquired)
0.717 0.283 0.000
E03.3 Postinfectious hypothyroidism
0.717 0.283 0.000
E12 Malnutrition-related diabetes mellitus
0.717 0.283 0.000
E13 Other specified diabetes mellitus
0.713 0.287 0.000
E26 Hyperaldosteronism
0.703 0.296 0.000
E14.1 With ketoacidosis
0.700 0.300 0.000
E24.8 Other Cushing's syndrome
0.696 0.304 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.687 0.313 0.000
E32 Diseases of thymus
0.687 0.313 0.000
E31 Polyglandular dysfunction
0.687 0.313 0.000
E30 Disorders of puberty, not elsewhere classified
0.687 0.313 0.000
E07.8 Other specified disorders of thyroid
0.685 0.315 0.000
E03.1 Congenital hypothyroidism without goitre
0.682 0.318 0.000
E14.0 With coma
0.681 0.319 0.000
E23.7 Disorder of pituitary gland, unspecified
0.677 0.323 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.671 0.329 0.000
E14.5 With peripheral circulatory complications
0.669 0.331 0.000
E25 Adrenogenital disorders
0.668 0.332 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.667 0.333 0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.664 0.336 0.000
E24.3 Ectopic ACTH syndrome
0.664 0.336 0.000
E24.1 Nelson's syndrome
0.664 0.336 0.000
E15 Nondiabetic hypoglycaemic coma
0.656 0.344 0.000
E14.4 With neurological complications
0.651 0.349 0.000
E03.0 Congenital hypothyroidism with diffuse goitre
0.642 0.358 0.000
E06 Thyroiditis
0.637 0.363 0.000
E46 Unspecified protein-energy malnutrition
0.636 0.364 0.000
E23.6 Other disorders of pituitary gland
0.635 0.365 0.000
E20 Hypoparathyroidism
0.635 0.365 0.000
E14.7 With multiple complications
0.632 0.368 0.000
K90 Intestinal malabsorption
0.631 0.369 0.000
E05.8 Other thyrotoxicosis
0.624 0.376 0.000
E23.1 Drug-induced hypopituitarism
0.623 0.377 0.000
E29.1 Testicular hypofunction
0.615 0.385 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.612 0.388 0.000
E16.8 Other specified disorders of pancreatic internal secretion
0.612 0.388 0.000
E16.4 Abnormal secretion of gastrin
0.612 0.388 0.000
E16.3 Increased secretion of glucagon
0.612 0.388 0.000
E28.9 Ovarian dysfunction, unspecified
0.595 0.405 0.000
E28.8 Other ovarian dysfunction
0.595 0.405 0.000
E28.1 Androgen excess
0.595 0.405 0.000
E28.0 Oestrogen excess
0.595 0.405 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.565 0.435 0.000
E45 Retarded development following protein-energy malnutrition
0.565 0.435 0.000
E43 Unspecified severe protein-energy malnutrition
0.565 0.435 0.000
E42 Marasmic kwashiorkor
0.565 0.435 0.000
E41 Nutritional marasmus
0.565 0.435 0.000
E40 Kwashiorkor
0.565 0.435 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.562 0.437 0.000
E22 Hyperfunction of pituitary gland
0.563 0.437 0.000
E13.9 Without complications
0.561 0.439 0.000
E14.2 Withrenal complications
0.559 0.441 0.000
E26.0 Primary hyperaldosteronism
0.544 0.456 0.000
E29.9 Testicular dysfunction, unspecified
0.544 0.456 0.000
E29.8 Other testicular dysfunction
0.544 0.456 0.000
E29.0 Testicular hyperfunction
0.544 0.456 0.000
E14.6 With other specified complications
0.543 0.456 0.000
E07.1 Dyshormogenetic goitre
0.536 0.463 0.000
E07.0 Hypersecretion of calcitonin
0.536 0.463 0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.514 0.486 0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.514 0.486 0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.514 0.486 0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.514 0.486 0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.514 0.486 0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.514 0.486 0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.514 0.486 0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.514 0.486 0.000
E12.9 Without complications
0.514 0.486 0.000
E12.8 With unspecified complications
0.514 0.486 0.000
E12.7 With multiple complications
0.514 0.486 0.000
E12.6 With other specified complications
0.514 0.486 0.000
E12.5 With peripheral circulatory complications
0.514 0.486 0.000
E12.4 With neurological complications
0.514 0.486 0.000
E12.3 With ophthalmic complications
0.514 0.486 0.000
E12.2 With renal complications
0.514 0.486 0.000
E12.1 With ketoacidosis
0.514 0.486 0.000
E12.0 With coma
0.514 0.486 0.000
E13.8 With unspecified complications
0.511 0.489 0.000
E13.7 With multiple complications
0.511 0.489 0.000
E13.6 With other specified complications
0.511 0.489 0.000
E13.5 With peripheral circulatory complications
0.511 0.489 0.000
E13.4 With neurological complications
0.511 0.489 0.000
E13.2 With renal complications
0.511 0.489 0.000
E13.1 With ketoacidosis
0.511 0.489 0.000
E13.0 With coma
0.511 0.489 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.508 0.492 0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.507 0.493 0.000
E06.5 Other chronic thyroiditis
0.504 0.495 0.000
E26.8 Other hyperaldosteronism
0.504 0.495 0.000
E26.1 Secondary hyperaldosteronism
0.504 0.495 0.000
K90.9 Intestinal malabsorption, unspecified
0.495 0.505 0.000
E21.2 Other hyperparathyroidism
0.493 0.507 0.000
E30.9 Disorder of puberty, unspecified
0.492 0.507 0.000
E30.8 Other disorders of puberty
0.492 0.507 0.000
E30.1 Precocious puberty
0.492 0.507 0.000
E30.0 Delayed puberty
0.492 0.507 0.000
E31.9 Polyglandular dysfunction, unspecified
0.492 0.507 0.000
E31.8 Other polyglandular dysfunction
0.492 0.507 0.000
E31.1 Polyglandular hyperfunction
0.492 0.507 0.000
E31.0 Autoimmune polyglandular failure
0.492 0.507 0.000
E32.9 Disease of thymus, unspecified
0.492 0.507 0.000
E32.8 Other diseases of thymus
0.492 0.507 0.000
E32.1 Abscess of thymus
0.492 0.507 0.000
E32.0 Persistent hyperplasia of thymus
0.492 0.507 0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.492 0.507 0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.492 0.507 0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.492 0.507 0.000
E21.0 Primary hyperparathyroidism
0.490 0.510 0.000
K90.8 Other intestinal malabsorption
0.482 0.518 0.000
E21.4 Other specified disorders of parathyroid gland
0.481 0.519 0.000
E25.9 Adrenogenital disorder, unspecified
0.479 0.521 0.000
E25.8 Other adrenogenital disorders
0.479 0.521 0.000
E16.1 Other hypoglycaemia
0.476 0.523 0.000
E26.9 Hyperaldosteronism, unspecified
0.476 0.524 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.471 0.528 0.000
E34 Other endocrine disorders
0.466 0.534 0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.461 0.539 0.000
E22.0 Acromegaly and pituitary gigantism
0.458 0.542 0.000
E21.3 Hyperparathyroidism, unspecified
0.458 0.542 0.000
E06.4 Drug-induced thyroiditis
0.457 0.543 0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.457 0.543 0.000
E06.0 Acute thyroiditis
0.457 0.543 0.000
E20.8 Other hypoparathyroidism
0.455 0.545 0.000
E20.1 Pseudohypoparathyroidism
0.455 0.545 0.000
E20.0 Idiopathic hypoparathyroidism
0.455 0.545 0.000
K90.3 Pancreatic steatorrhoea
0.453 0.547 0.000
K90.2 Blind loop syndrome, not elsewhere classified
0.453 0.547 0.000
K90.1 Tropical sprue
0.453 0.547 0.000
E13.3 With ophthalmic complications
0.440 0.560 0.000
E06.9 Thyroiditis, unspecified
0.437 0.563 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.434 0.566 0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.432 0.568 0.000
E06.1 Subacute thyroiditis
0.426 0.574 0.000
E28.2 Polycystic ovarian syndrome
0.414 0.586 0.000
E44.1 Mild protein-energy malnutrition
0.405 0.595 0.000
E44.0 Moderate protein-energy malnutrition
0.405 0.595 0.000
E22.8 Other hyperfunction of pituitary gland
0.403 0.596 0.000
E20.9 Hypoparathyroidism, unspecified
0.403 0.597 0.000
E06.3 Autoimmune thyroiditis
0.365 0.635 0.000
E04 Other non-toxic goitre
0.359 0.641 0.000
E22.1 Hyperprolactinaemia
0.351 0.649 0.000
E34.3 Short stature, not elsewhere classified
0.350 0.649 0.000
E34.8 Other specified endocrine disorders
0.343 0.657 0.000
E34.5 Androgen resistance syndrome
0.334 0.665 0.000
E34.4 Constitutional tall stature
0.334 0.665 0.000
E34.2 Ectopic hormone secretion, not elsewhere classified
0.334 0.665 0.000
E34.1 Other hypersecretion of intestinal hormones
0.334 0.665 0.000
E65-E68 Obesity and other hyperalimentation
0.314 0.686 0.000
E27 Other disorders of adrenal gland
0.307 0.693 0.000
E04.0 Non-toxic diffuse goitre
0.302 0.698 0.000
E50-E64 Other nutritional deficiencies
0.285 0.714 0.001
E27.8 Other specified disorders of adrenal gland
0.261 0.739 0.000
E04.8 Other specified non-toxic goitre
0.257 0.743 0.000
E23.0 Hypopituitarism
0.255 0.745 0.000
E34.0 Carcinoid syndrome
0.248 0.752 0.001
E27.1 Primary adrenocortical insufficiency
0.232 0.767 0.000
I35.0 Aortic (valve) stenosis
0.232 0.768 0.000
E67 Other hyperalimentation
0.225 0.775 0.000
E68 Sequelae of hyperalimentation
0.225 0.775 0.000
E27.5 Adrenomedullary hyperfunction
0.220 0.779 0.000
E27.0 Other adrenocortical overactivity
0.220 0.779 0.000
E51 Thiamine deficiency
0.211 0.788 0.001
E63 Other nutritional deficiencies
0.210 0.789 0.001
E54 Ascorbic acid deficiency
0.207 0.793 0.001
E34.9 Endocrine disorder, unspecified
0.206 0.793 0.001
E64 Sequelae of malnutrition and other nutritional deficiencies
0.204 0.795 0.001
E50 Vitamin A deficiency
0.204 0.795 0.001
E60 Dietary zinc deficiency
0.204 0.795 0.001
E59 Dietary selenium deficiency
0.204 0.795 0.001
E52 Niacin deficiency [pellagra]
0.204 0.795 0.001
E27.3 Drug-induced adrenocortical insufficiency
0.202 0.798 0.000
G35 Multiple sclerosis
0.000 0.804 0.196
E04.1 Non-toxic single thyroid nodule
0.194 0.806 0.000
E56 Other vitamin deficiencies
0.192 0.808 0.001
E61 Deficiency of other nutrient elements
0.178 0.821 0.000
J45.9 Asthma, unspecified
0.173 0.827 0.000
J43.9 Emphysema, unspecified
0.166 0.834 0.000
E04.2 Non-toxic multinodular goitre
0.163 0.837 0.000
E58 Dietary calcium deficiency
0.162 0.838 0.001
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.162 0.838 0.001
E67.8 Other specified hyperalimentation
0.162 0.838 0.000
E67.3 Hypervitaminosis D
0.162 0.838 0.000
E67.2 Megavitamin-B6 syndrome
0.162 0.838 0.000
E67.1 Hypercarotenaemia
0.162 0.838 0.000
E67.0 Hypervitaminosis A
0.162 0.838 0.000
E51.2 Wernicke's encephalopathy
0.159 0.841 0.000
E63.9 Nutritional deficiency, unspecified
0.157 0.843 0.001
E65 Localised adiposity
0.156 0.844 0.000
E53 Deficiency of other B group vitamins
0.152 0.847 0.000
E51.9 Thiamine deficiency, unspecified
0.152 0.848 0.001
E51.8 Other manifestations of thiamine deficiency
0.152 0.848 0.001
E51.1 Beriberi
0.152 0.848 0.001
E63.8 Other specified nutritional deficiencies
0.151 0.848 0.001
E63.1 Imbalance of constituents of food intake
0.151 0.848 0.001
E63.0 Essential fatty acid [EFA] deficiency
0.151 0.848 0.001
E07.9 Disorder of thyroid, unspecified
0.149 0.851 0.000
E50.9 Vitamin A deficiency, unspecified
0.147 0.853 0.001
E50.8 Other manifestations of vitamin A deficiency
0.147 0.853 0.001
E50.7 Other ocular manifestations of vitamin A deficiency
0.147 0.853 0.001
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.147 0.853 0.001
E50.5 Vitamin A deficiency with night blindness
0.147 0.853 0.001
E50.4 Vitamin A deficiency with keratomalacia
0.147 0.853 0.001
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.147 0.853 0.001
E50.2 Vitamin A deficiency with corneal xerosis
0.147 0.853 0.001
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.147 0.853 0.001
E50.0 Vitamin A deficiency with conjunctival xerosis
0.147 0.853 0.001
E64.9 Sequelae of unspecified nutritional deficiency
0.147 0.853 0.001
E64.8 Sequelae of other nutritional deficiencies
0.147 0.853 0.001
E64.3 Sequelae of rickets
0.147 0.853 0.001
E64.2 Sequelae of vitamin C deficiency
0.147 0.853 0.001
E64.1 Sequelae of vitamin A deficiency
0.147 0.853 0.001
E64.0 Sequelae of protein-energy malnutrition
0.147 0.853 0.001
J43 Emphysema
0.145 0.854 0.000
E27.2 Addisonian crisis
0.142 0.858 0.001
J45 Asthma
0.142 0.858 0.000
E27.9 Disorder of adrenal gland, unspecified
0.139 0.860 0.001
E56.9 Vitamin deficiency, unspecified
0.138 0.862 0.001
E56.8 Deficiency of other vitamins
0.138 0.862 0.001
E56.0 Deficiency of vitamin E
0.138 0.862 0.001
J40-J47 Chronic lower respiratory diseases
0.136 0.864 0.000
J44 Other chronic obstructive pulmonary disease
0.136 0.864 0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection
0.135 0.865 0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.134 0.866 0.000
E61.9 Deficiency of nutrient element, unspecified
0.128 0.871 0.000
E61.8 Deficiency of other specified nutrient elements
0.128 0.871 0.000
E61.7 Deficiency of multiple nutrient elements
0.128 0.871 0.000
E61.6 Vanadium deficiency
0.128 0.871 0.000
E61.5 Molybdenum deficiency
0.128 0.871 0.000
E61.4 Chromium deficiency
0.128 0.871 0.000
E61.3 Manganese deficiency
0.128 0.871 0.000
E61.0 Copper deficiency
0.128 0.871 0.000
E11 Non-insulin-dependent diabetes mellitus
0.127 0.873 0.000
E55 Vitamin D deficiency
0.124 0.874 0.002
E56.1 Deficiency of vitamin K
0.125 0.874 0.001
E61.2 Magnesium deficiency
0.124 0.875 0.000
E53.9 Vitamin B deficiency, unspecified
0.119 0.881 0.000
E11.1 With ketoacidosis
0.112 0.888 0.000
E53.1 Pyridoxine deficiency
0.109 0.890 0.000
E53.0 Riboflavin deficiency
0.109 0.890 0.000
E61.1 Iron deficiency
0.107 0.893 0.000
E11.2 With renal complications
0.106 0.894 0.000
E70-E90 Metabolic disorders
0.105 0.895 0.001
E11.7 With multiple complications
0.105 0.895 0.000
J43.1 Panlobular emphysema
0.104 0.895 0.000
J43.0 MacLeod's syndrome
0.104 0.895 0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.103 0.897 0.000
J45.1 Nonallergic asthma
0.103 0.897 0.000
E89.0 Postprocedural hypothyroidism
0.102 0.898 0.000
E04.9 Non-toxic goitre, unspecified
0.098 0.902 0.000
J43.2 Centrilobular emphysema
0.097 0.903 0.000
J41 Simple and mucopurulent chronic bronchitis
0.096 0.904 0.000
J43.8 Other emphysema
0.093 0.906 0.000
R40.0 Somnolence
0.093 0.907 0.000
E83 Disorders of mineral metabolism
0.015 0.908 0.078
E55.0 Rickets, active
0.089 0.909 0.002
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.088 0.912 0.000
J45.8 Mixed asthma
0.084 0.916 0.000
J46 Status asthmaticus
0.084 0.916 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.076 0.923 0.001
E70 Disorders of aromatic amino-acid metabolism
0.076 0.923 0.001
E84 Cystic fibrosis
0.076 0.924 0.001
E77 Disorders of glycoprotein metabolism
0.075 0.924 0.001
E76 Disorders of glycosaminoglycan metabolism
0.075 0.924 0.001
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.075 0.924 0.001
E72 Other disorders of amino-acid metabolism
0.075 0.924 0.001
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.075 0.924 0.001
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.075 0.924 0.001
E11.8 With unspecified complications
0.075 0.924 0.000
E74 Other disorders of carbohydrate metabolism
0.074 0.925 0.001
E14.9 Without complications
0.075 0.925 0.000
E89.2 Postprocedural hypoparathyroidism
0.075 0.925 0.000
E73 Lactose intolerance
0.074 0.925 0.001
E85 Amyloidosis
0.074 0.926 0.001
E11.6 With other specified complications
0.074 0.926 0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.074 0.926 0.000
E89.8 Other postprocedural endocrine and metabolic disorders
0.074 0.926 0.000
E89.5 Postprocedural testicular hypofunction
0.074 0.926 0.000
E89.1 Postprocedural hypoinsulinaemia
0.074 0.926 0.000
E11.0 With coma
0.071 0.928 0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis
0.069 0.931 0.000
J41.1 Mucopurulent chronic bronchitis
0.069 0.931 0.000
E11.5 With peripheral circulatory complications
0.069 0.931 0.000
R40 Somnolence, stupor and coma
0.068 0.932 0.000
J41.0 Simple chronic bronchitis
0.068 0.932 0.000
E83.9 Disorder of mineral metabolism, unspecified
0.011 0.934 0.056
E83.8 Other disorders of mineral metabolism
0.011 0.934 0.056
E83.2 Disorders of zinc metabolism
0.011 0.934 0.056
E83.0 Disorders of copper metabolism
0.011 0.934 0.056
E89.3 Postprocedural hypopituitarism
0.063 0.937 0.000
E89.4 Postprocedural ovarian failure
0.063 0.937 0.000
G35-G37 Demyelinating diseases of the central nervous system
0.000 0.938 0.062
J45.0 Predominantly allergic asthma
0.060 0.940 0.000
E88 Other metabolic disorders
0.059 0.940 0.000
E79 Disorders of purine and pyrimidine metabolism
0.057 0.941 0.001
E85.9 Amyloidosis, unspecified
0.058 0.942 0.000
E74.0 Glycogen storage disease
0.056 0.944 0.001
E85.8 Other amyloidosis
0.056 0.944 0.000
E70.3 Albinism
0.055 0.944 0.001
E85.3 Secondary systemic amyloidosis
0.055 0.944 0.000
E84.9 Cystic fibrosis, unspecified
0.055 0.945 0.001
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.055 0.945 0.001
E70.8 Other disorders of aromatic amino-acid metabolism
0.055 0.945 0.001
E70.2 Disorders of tyrosine metabolism
0.055 0.945 0.001
E70.1 Other hyperphenylalaninaemias
0.055 0.945 0.001
E70.0 Classical phenylketonuria
0.055 0.945 0.001
E84.8 Cystic fibrosis with other manifestations
0.054 0.945 0.001
E84.1 Cystic fibrosis with intestinal manifestations
0.054 0.945 0.001
E84.0 Cystic fibrosis with pulmonary manifestations
0.054 0.945 0.001
E75.6 Lipid storage disorder, unspecified
0.054 0.945 0.001
E75.4 Neuronal ceroid lipofuscinosis
0.054 0.945 0.001
E75.3 Sphingolipidosis, unspecified
0.054 0.945 0.001
E75.2 Other sphingolipidosis
0.054 0.945 0.001
E75.1 Other gangliosidosis
0.054 0.945 0.001
E75.0 GM2 gangliosidosis
0.054 0.945 0.001
E71.3 Disorders of fatty-acid metabolism
0.054 0.945 0.001
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.054 0.945 0.001
E71.1 Other disorders of branched-chain amino-acid metabolism
0.054 0.945 0.001
E71.0 Maple-syrup-urine disease
0.054 0.945 0.001
E72.9 Disorder of amino-acid metabolism, unspecified
0.054 0.945 0.001
E72.8 Other specified disorders of amino-acid metabolism
0.054 0.945 0.001
E72.5 Disorders of glycine metabolism
0.054 0.945 0.001
E72.4 Disorders of ornithine metabolism
0.054 0.945 0.001
E72.3 Disorders of lysine and hydroxylysine metabolism
0.054 0.945 0.001
E72.2 Disorders of urea cycle metabolism
0.054 0.945 0.001
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.054 0.945 0.001
E72.0 Disorders of amino-acid transport
0.054 0.945 0.001
E75.5 Other lipid storage disorders
0.054 0.945 0.001
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.054 0.945 0.001
E76.8 Other disorders of glucosaminoglycan metabolism
0.054 0.945 0.001
E76.3 Mucopolysaccharidosis, unspecified
0.054 0.945 0.001
E76.2 Other mucopolysaccharidoses
0.054 0.945 0.001
E76.1 Mucopolysaccharidosis, type II
0.054 0.945 0.001
E76.0 Mucopolysaccharidosis, type I
0.054 0.945 0.001
E77.9 Disorder of glycoprotein metabolism, unspecified
0.054 0.945 0.001
E77.8 Other disorders of glycoprotein metabolism
0.054 0.945 0.001
E77.1 Defects in glycoprotein degradation
0.054 0.945 0.001
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.054 0.945 0.001
R40.2 Coma, unspecified
0.054 0.946 0.000
E74.9 Disorder of carbohydrate metabolism, unspecified
0.053 0.946 0.001
E74.8 Other specified disorders of carbohydrate metabolism
0.053 0.946 0.001
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.053 0.946 0.001
E74.2 Disorders of galactose metabolism
0.053 0.946 0.001
E74.1 Disorders of fructose metabolism
0.053 0.946 0.001
E73.8 Other lactose intolerance
0.053 0.946 0.001
E73.1 Secondary lactase deficiency
0.053 0.946 0.001
E73.0 Congenital lactase deficiency
0.053 0.946 0.001
E85.2 Heredofamilial amyloidosis, unspecified
0.053 0.947 0.001
E85.1 Neuropathic heredofamilial amyloidosis
0.053 0.947 0.001
E85.0 Nonneuropathic heredofamilial amyloidosis
0.053 0.947 0.001
E73.9 Lactose intolerance, unspecified
0.052 0.947 0.000
E83.4 Disorders of magnesium metabolism
0.003 0.949 0.047
E74.3 Other disorders of intestinal carbohydrate absorption
0.049 0.950 0.000
E88.3 Tumour lysis syndrome
0.049 0.950 0.000
R40.1 Stupor
0.049 0.951 0.000
E86 Volume depletion
0.049 0.951 0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.048 0.952 0.000
E78.2 Mixed hyperlipidaemia
0.046 0.954 0.000
E11.4 With neurological complications
0.045 0.955 0.000
R40-R46 Symptoms and signs involving cognition, perception, emotional state and behaviour
0.045 0.955 0.000
E88.2 Lipomatosis, not elsewhere classified
0.043 0.956 0.000
E83.3 Disorders of phosphorus metabolism
0.010 0.956 0.034
J44.8 Other specified chronic obstructive pulmonary disease
0.043 0.957 0.000
G36 Other acute disseminated demyelination
0.000 0.957 0.043
J42 Unspecified chronic bronchitis
0.043 0.957 0.000
E78.4 Other hyperlipidaemia
0.042 0.957 0.000
R42 Dizziness and giddiness
0.042 0.958 0.000
E78.1 Pure hyperglyceridaemia
0.042 0.958 0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.041 0.958 0.001
E79.8 Other disorders of purine and pyrimidine metabolism
0.041 0.958 0.001
E79.1 Lesch-Nyhan syndrome
0.041 0.958 0.001
E88.1 Lipodystrophy, not elsewhere classified
0.041 0.959 0.000
E88.9 Metabolic disorder, unspecified
0.041 0.959 0.000
E88.8 Other specified metabolic disorders
0.040 0.959 0.000
E80 Disorders of porphyrin and bilirubin metabolism
0.039 0.960 0.001
E66 Obesity
0.038 0.962 0.000
R43 Disturbances of smell and taste
0.038 0.962 0.000
E11.3 With ophthalmic complications
0.038 0.962 0.000
K90-K93 Other diseases of the digestive system
0.037 0.963 0.000
E85.4 Organ-limited amyloidosis
0.036 0.963 0.001
G37 Other demyelinating diseases of central nervous system
0.000 0.964 0.036
R41 Other symptoms and signs involving cognitive functions and awareness
0.036 0.964 0.000
E78.3 Hyperchylomicronaemia
0.036 0.964 0.000
R46 Symptoms and signs involving appearance and behaviour
0.036 0.964 0.000
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness
0.036 0.964 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.965 0.035
R41.1 Anterograde amnesia
0.033 0.967 0.000
R43.8 Other and unspecified disturbances of smell and taste
0.033 0.967 0.000
R46.4 Slowness and poor responsiveness
0.032 0.968 0.000
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament
0.000 0.968 0.032
R43.0 Anosmia
0.031 0.969 0.000
E53.8 Deficiency of other specified B group vitamins
0.031 0.969 0.000
G36.9 Acute disseminated demyelination, unspecified
0.000 0.969 0.031
G36.8 Other specified acute disseminated demyelination
0.000 0.969 0.031
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.000 0.969 0.031
J44.9 Chronic obstructive pulmonary disease, unspecified
0.030 0.970 0.000
E80.6 Other disorders of bilirubin metabolism
0.029 0.970 0.001
G36.0 Neuromyelitis optica [Devic]
0.000 0.970 0.029
E78.6 Lipoprotein deficiency
0.029 0.971 0.000
E80.7 Disorder of bilirubin metabolism, unspecified
0.028 0.971 0.001
E80.5 Crigler-Najjar syndrome
0.028 0.971 0.001
E80.3 Defects of catalase and peroxydase
0.028 0.971 0.001
E80.0 Hereditary erythropoietic porphyria
0.028 0.971 0.001
G37.8 Other specified demyelinating diseases of central nervous system
0.000 0.972 0.028
E66.1 Drug-induced obesity
0.028 0.972 0.000
E80.2 Other porphyria
0.026 0.973 0.001
R43.2 Parageusia
0.027 0.973 0.000
K93 Disorders of other digestive organs in diseases classified elsewhere
0.026 0.973 0.000
G37.5 Concentric sclerosis [Balo]
0.000 0.974 0.026
G37.4 Subacute necrotising myelitis
0.000 0.974 0.026
G37.2 Central pontine myelinolysis
0.000 0.974 0.026
G37.1 Central demyelination of corpus callosum
0.000 0.974 0.026
G37.0 Diffuse sclerosis
0.000 0.974 0.026
R46.7 Verbosity and circumstantial detail obscuring reason for contact
0.026 0.974 0.000
R46.6 Undue concern and preoccupation with stressful events
0.026 0.974 0.000
R46.5 Suspiciousness and marked evasiveness
0.026 0.974 0.000
R46.3 Overactivity
0.026 0.974 0.000
R46.1 Bizarre personal appearance
0.026 0.974 0.000
R46.0 Very low level of personal hygiene
0.026 0.974 0.000
E80.1 Porphyria cutanea tarda
0.025 0.975 0.001
R46.2 Strange and inexplicable behaviour
0.025 0.975 0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.023 0.975 0.002
R46.8 Other symptoms and signs involving appearance and behaviour
0.025 0.975 0.000
G37.9 Demyelinating disease of central nervous system, unspecified
0.000 0.975 0.025
R43.1 Parosmia
0.024 0.976 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.977 0.023
L98.8 Other specified disorders of skin and subcutaneous tissue
0.022 0.978 0.000
E66.2 Extreme obesity with alveolar hypoventilation
0.022 0.978 0.000
C82.0 Small cleaved cell, follicular
0.000 0.979 0.021
R41.0 Disorientation, unspecified
0.021 0.979 0.000
E66.8 Other obesity
0.021 0.979 0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.020 0.979 0.000
E78.8 Other disorders of lipoprotein metabolism
0.020 0.980 0.000
C34.3 Lower lobe, bronchus or lung
0.020 0.980 0.000
I35 Nonrheumatic aortic valve disorders
0.019 0.981 0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.019 0.981 0.000
K93.1 Megacolon in Chagas' disease
0.019 0.981 0.000
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.019 0.981 0.000
J40 Bronchitis, not specified as acute or chronic
0.019 0.981 0.000
C82.3 Follicular lymphoma grade IIIa
0.000 0.981 0.019
E83.5 Disorders of calcium metabolism
0.002 0.981 0.016
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.983 0.017
R44 Other symptoms and signs involving general sensations and perceptions
0.017 0.983 0.000
K86.0 Alcohol-induced chronic pancreatitis
0.017 0.983 0.000
K86.1 Other chronic pancreatitis
0.017 0.983 0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.000 0.983 0.016
C82.6 Cutaneous follicle centre lymphoma
0.000 0.983 0.017
C82.5 Diffuse follicle centre lymphoma
0.000 0.983 0.017
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.984 0.015
C82.4 Follicular lymphoma grade IIIb
0.000 0.984 0.015
D50.9 Iron deficiency anaemia, unspecified
0.015 0.985 0.000
E66.0 Obesity due to excess calories
0.015 0.985 0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.